IP Library Assignment 060141/0182
Patent Assignment
Reel/Frame 060141/0182

Assignment of Assignor's Interest

Recorded: 2022-06-08 Pages: 6
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-07-09
DUFFY, BRYAN CORDELL
Executed: 2013-07-12
LIU, SHUANG
Executed: 2013-07-12
WANG, RUIFANG
Executed: 2013-07-12
JIANG, MAY XIAOWU
Executed: 2013-07-12
MARTIN, GREGORY SCOTT
Executed: 2013-07-12
WAGNER, GREGORY STEVEN
Executed: 2013-07-26
YOUNG, PETER RONALD
Executed: 2013-07-10
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, ALBERTA, T2X 1M2, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Application: 16/940,785 →
Publication: US 2021/0177855
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 2022
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 060141/0204 →
Assignment of Assignor's Interest Jun 8, 2022
From: QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; DUFFY, BRYAN CORDELL; LIU, SHUANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 060314/0739 →
Change of Name Jun 8, 2022
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 060314/0745 →
Assignment of Assignor's Interest Jun 8, 2022
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 060314/0756 →